IBI-Ag is a startup based in Israel, most recent round Series A, 1 tracked investor.
Based in Israel, IBI-Ag is a startup. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
IBI-Ag develops and manufactures selective biological insecticides for agriculture using antibody- and protein-based biotechnologies to control pests with minimal environmental and health impact. The company has also developed an AI-driven de novo protein design platform for creating novel bioinsecticide proteins.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.